Premier Perspectives The blog for insider insights in clinical development Recent Posts By expertise area All expertise areas Medical DeviceRare DiseaseOncology & HematologyDiagnosticsDigital TherapeuticsMedTechPediatricsNeuroscienceAnalgesiaDermatologyOtherCOVID-19Cell & Gene TherapyWomen's HealthReal-World & Late PhaseCareers By functional area All functional areas Development StrategyClinical Research: Phase 1 - Phase 4ConsultingData Management & BiostatisticsFunctional Service Provider (FSP)Global ComplianceMedical and Regulatory AffairsPatient and Stakeholder EngagementProject ManagementQualityReal-World Science and Late PhaseSafety/PharmacovigilanceStudy DesignStudy Start-UpOtherCOVID-19Product Development Medical and Regulatory Affairs FDA’s LDT Proposal and Its Impact on Clinical and Regulatory Professionals By Charles Chrisawn March 6, 2024 Consulting Getting the Support You Need at Every Step of the CE Marking Process By Michael Edwards March 5, 2024 Clinical ResearchPhase 1 - Phase 4 5 Stages of Medical Device Development By Premier Research March 1, 2024 Why Rare Disease Day Matters to Us By Premier Research February 29, 2024 Clinical ResearchPhase 1 - Phase 4 Deviating from the Conventional: Decentralizing Pediatric Rare Disease Clinical Research By Adam Bloomfield February 19, 2024 Clinical ResearchPhase 1 - Phase 4 Advancing Health Outcomes for All: Addressing Diversity and Ethnicity Data Challenges in Global Clinical Research By Stacy Weil February 7, 2024 Previous 1 2 3 4 … 56 Next × ALSO OF INTERESTKey Considerations When Designing a Phase 1...Nostalgia or Shell Shock? Assessing PTSD Is a...Gene Therapy 101: From the 1960s to Today